1. Coons SJ, Gwaltney CJ, Hays RD, et al. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force Report. Value Health 2009;12:419-29. Available from: http://www.ispor.org/workpaper/patient_reported_outcomes/Coons.pdf. [Accessed March 26, 2013].
2. US Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. December 2009. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. [Accessed February 19, 2011].
3. European Medicines Agency. Reflection paper on the regulatory guidance for the use of health related quality of life (HRQL) measures in the evaluation of medicinal products. 2005. Available from: http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003637.pdf. [Accessed February 22, 2011].
4. Paty J, Stokes T. Electronic diaries, part 1: what is a subject diary, and how do regulations apply. Appl Clin Trials 2002. Available from: http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/article/articleDetail.jsp?id=83521. [Accessed March 23, 2011].
5. Collecting reliable and valid real-time patient experience data;Hufford;Drug Inf J,2001